SLC12A3 and Gitelman syndrome: Consistent with NCC dysfunction in Gitelman’s syndrome is the lesser increase in urinary excretion of Na+ and Cl− to hydrochlorothiazide (single, therapeutic dose of p.o. 50 mg; Table 1k; Dose/Concentration of TZD).